Sclerotherapy: Indications and safety volumes
Phlebology
.
2024 Mar;39(2):135-138.
doi: 10.1177/02683555231211092.
Epub 2023 Oct 29.
Authors
Matthew Tan
1
,
Hernan Bauza Moreno
2
,
Beate Bechter-Hugl
3
,
Sergio Gianesini
4
,
David Connor
5
,
Kurosh Parsi
5
,
Alun H Davies
1
Affiliations
1
Department of Surgery and Cancer, Imperial College London, London, UK.
2
Department of General Surgery, Hospital Italiano de Buenos Aires, Argentina.
3
Department of Vascular Surgery, Centre for Lymphedema, UZ Leuven - University Hospitals Leuven, Leuven, Belgium.
4
Department of Translational Medicine, University of Ferrara, Ferrara, Italy.
5
Department of Dermatology, St Vincent's Hospital Sydney, Sydney, Australia.
PMID:
37899570
PMCID:
PMC10877989
DOI:
10.1177/02683555231211092
No abstract available
Keywords:
chronic venous disease; foam sclerotherapy; guideline; sclerotherapy.
MeSH terms
Humans
Sclerosing Solutions / therapeutic use
Sclerotherapy* / adverse effects
Treatment Outcome
Varicose Veins* / drug therapy
Substances
Sclerosing Solutions